Direct Flow Medical Clears $27 Million Series B
Monday, October 22, 2007 5:00:00 AM PDT | VentureDeal Staff
SANTA ROSA, CA -- Medical device maker Direct Flow Medical said that it has completed its second round of venture capital financing, receiving $27 million from a syndicate of firms and strategic investors.
Direct Flow is developing a percutaneous aortic tissue valve prosthesis that provides patients with a safer way to treat cardiac valve conditions. The prosthesis can be placed using a minimally-invasive procedure.
Investors were led by Johnson & Johnson Development Corporation and Foundation Medical Partners, and included VantagePoint Venture Partners, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.
Email Page | Print Page